Patents by Inventor Lorraine Gudas

Lorraine Gudas has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods for preventing and treating oral cancers
    Patent number: 9895410
    Abstract: Methods for preventing or treating oral cancers, and/or reducing the severity of symptoms of oral cancers are described. The methods comprise administering an effective amount of an aromatic-cationic peptide to a subject in need thereof to normalize expression levels of genes involved in oral carcinogenesis.
    Type: Grant
    Filed: December 11, 2014
    Date of Patent: February 20, 2018
    Assignee: Cornell University
    Inventors: Hazel Szeto, Lorraine Gudas, Xiaohan Tang
  • METHODS FOR PREVENTING AND TREATING ORAL CANCERS
    Publication number: 20170000840
    Abstract: The disclosure provides methods for preventing or treating oral cancers, and/or reducing the severity of symptoms of oral cancers. In particular, the present technology relates to administering an effective amount of an aromatic-cationic peptide to a subject in need thereof to normalize expression levels of genes involved in oral carcinogenesis.
    Type: Application
    Filed: December 11, 2014
    Publication date: January 5, 2017
    Inventors: Hazel Szeto, Lorraine Gudas, Xiaohan Tang
  • Detection and modulation of cancer stem cells
    Publication number: 20050277162
    Abstract: The invention relates to method for detecting and modulating the expression and activity of REX-1. As described herein, REX-1 is expressed in certain cancer cells, including cancer stem cells. The invention also provides methods for detecting and/or treating cancer.
    Type: Application
    Filed: June 8, 2005
    Publication date: December 15, 2005
    Inventor: Lorraine Gudas
  • Treatment of estrogen-receptor positive breast cancer and estrogen-receptor negative breast cancer with retinoid with CH.sub.2 OH at the side chain terminal position
    Patent number: 6150421
    Abstract: Certain retinoids with CH.sub.2 OH at the side chain terminal position, preferably 4-oxoretinol, inhibit growth of estrogen-receptor positive and estrogen-receptor negative breast cancer tumor cell lines and have utility for adjuvant therapy and treatment of metastatic disease.
    Type: Grant
    Filed: June 2, 1998
    Date of Patent: November 21, 2000
    Assignee: Cornell Research Foundation, Inc.
    Inventors: Lorraine Gudas, Fadila Derguini